Avalo Therapeutics, Inc. ($AVTX)
Doyle Mittie โ Chief Medical Officer
Shares
679
Price
$16.00
Total Value
$10,864.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Doyle Mittie |
|---|---|
| Title | Chief Medical Officer |
| Transaction Date | May 28, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jun 1, 2026 |
| Shares Sold | 679 |
| Price per Share | $16.00 |
| Total Value | $10,864.00 |
| Shares Owned After | 47,122 |
| Derivative | No |
| Accession Number | 0001918845-26-000016 |
| Document | View SEC Filing |